Syneos Health

$64.50
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.

+$1.88 (+3.00%) As of 1:11 PM EST today

Why Robinhood?

You can buy or sell Syneos Health and other stocks, options, and ETFs commission-free!

About SYNH

Syneos Health, Inc. provides outsourced clinical development and commercialization services to biopharmaceutical companies. It operates through the following business segments: Clinical Solutions and Commercial Solutions. The Clinical Solutions segment offers clinical development services spanning Phase I to Phase IV, including global studies, as well as unbundled service offerings such as clinical monitoring, investigator recruitment, patient recruitment, data management, and study startup to assist customers with their drug development process. The Commercial Solutions segment provides commercialization services, including outsourced field selling solutions, medication adherence, communications, and consulting services. The company was founded in 1998 and is headquartered in Morrisville, NC. The listed name for SYNH is Syneos Health, Inc. Class A Common Stock.

CEO

Alistair John Macdonald

Employees

24,000

Headquarters

Morrisville, North Carolina

Founded

1998

Market Cap

6.71B

Price-Earnings Ratio

34.32

Dividend Yield

—

Average Volume

978.23K

High Today

$64.91

Low Today

$62.71

Open Price

$62.92

Volume

418.24K

52 Week High

$74.25

52 Week Low

$30.02

Collections

Analyst Ratings

67%

of 15 ratings

Buy

67%

Hold

33%

Sell

SYNH Earnings

$0.00

$0.35

$0.69

$1.04

Q1 FY19

Q2 FY19

Q3 FY19

Q4 FY19

Q1 FY20

Q2 FY20

Q3 FY20

Q4 FY20

Estimated

— per share

Actual

Expected Feb 18, Pre-Market